MedPath

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction

Completed
Conditions
Infarction, Myocardial
Registration Number
NCT00196261
Lead Sponsor
Deutsches Herzzentrum Muenchen
Brief Summary

The purpose of this study is to investigate the performance of established and new risk preditors in predicting long term-mortality (up to ten years) of post-infarction patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3500
Inclusion Criteria

acute myocardial infarction

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Deutsches Herzzentrum Muenchen

🇩🇪

Munich, Germany

1. Medizinische Klinik, Klinikum rechts der Isar

🇩🇪

Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath